A New Chapter in AI-Driven Drug Discovery as Recursion Completes Exscientia Acquisition
The landscape of AI-powered biotechnology has undergone a fundamental restructuring with the finalization of Recursion Pharmaceuticals' acquisition of Exscientia. This ...
